US Stock MarketDetailed Quotes

AKYA Akoya Biosciences

Watchlist
  • 1.125
  • -0.005-0.44%
Close May 7 16:00 ET
  • 1.159
  • +0.034+3.02%
Post 16:40 ET
56.11MMarket Cap-1.00P/E (TTM)

Akoya Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-15.48%81.67M
-19.42%21.34M
-25.39%18.81M
-1.52%23.16M
-14.29%18.35M
29.09%96.63M
24.83%26.49M
33.75%25.22M
31.45%23.52M
26.73%21.41M
Operating revenue
-15.48%81.67M
-19.42%21.34M
-25.39%18.81M
-1.52%23.16M
-14.29%18.35M
29.09%96.63M
24.83%26.49M
33.75%25.22M
31.45%23.52M
26.73%21.41M
Cost of revenue
-16.20%33.79M
-29.51%6.96M
-28.66%7.09M
-14.27%9.78M
9.37%9.97M
28.15%40.33M
7.57%9.87M
25.10%9.94M
51.00%11.41M
34.11%9.12M
Gross profit
-14.97%47.88M
-13.42%14.39M
-23.25%11.72M
10.48%13.39M
-31.84%8.38M
29.76%56.31M
37.97%16.62M
40.06%15.28M
17.16%12.12M
21.76%12.29M
Operating expense
-20.72%89.06M
-20.93%20.12M
-27.93%19.15M
-20.91%24.38M
-13.85%25.42M
2.50%112.34M
-12.69%25.44M
-2.35%26.57M
10.87%30.83M
15.92%29.5M
Selling and administrative expenses
-20.66%69.32M
-21.88%15.69M
-27.55%14.67M
-20.13%19.09M
-14.10%19.86M
9.68%87.36M
-4.13%20.08M
1.65%20.25M
16.10%23.91M
27.10%23.12M
Research and development costs
-20.94%19.75M
-17.37%4.43M
-29.14%4.47M
-23.62%5.29M
-12.92%5.55M
7.60%24.97M
-16.68%5.36M
15.51%6.31M
23.67%6.92M
11.62%6.38M
Operating profit
26.50%-41.18M
35.07%-5.73M
34.25%-7.42M
41.24%-11M
0.99%-17.04M
15.37%-56.03M
48.39%-8.82M
30.73%-11.29M
-7.15%-18.71M
-12.08%-17.21M
Net non-operating interest income expense
-50.28%-7.92M
-59.86%-2.21M
-80.60%-2.1M
-34.77%-1.94M
-29.95%-1.68M
-39.58%-5.27M
-7.64%-1.38M
-19.73%-1.17M
-80.88%-1.44M
-77.30%-1.29M
Non-operating interest income
-28.17%2.51M
-58.38%380K
-51.49%521K
-9.36%668K
22.48%937K
349.03%3.49M
61.59%913K
689.71%1.07M
1,264.81%737K
3,377.27%765K
Non-operating interest expense
19.04%10.43M
12.78%2.59M
17.24%2.63M
19.82%2.61M
27.17%2.61M
92.38%8.76M
24.15%2.29M
101.89%2.24M
156.18%2.18M
174.23%2.05M
Other net income (expense)
-208.84%-6.11M
56.11%-273K
-115.44%-963K
73.54%-168K
-1,612.00%-4.71M
-271.29%-1.98M
-18.48%-622K
23.20%-447K
-172.99%-635K
7.09%-275K
Special income (charges)
-239.00%-5.55M
102.59%16K
-253.82%-927K
83.40%-88K
-1,903.08%-4.55M
-1,703.92%-1.64M
-24.14%-617K
26.61%-262K
-145.85%-530K
-13.50%-227K
-Less：Restructuring and merger&acquisition
57.40%2.58M
-102.59%-16K
253.82%927K
-83.40%88K
594.27%1.58M
1,703.92%1.64M
24.14%617K
-26.61%262K
145.85%530K
13.50%227K
-Less:Impairment of capital assets
--2.97M
--0
--0
--0
--2.97M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-65.01%-566K
-5,680.00%-289K
80.54%-36K
23.81%-80K
-235.42%-161K
45.98%-343K
82.14%-5K
17.78%-185K
63.29%-105K
50.00%-48K
Income before tax
12.74%-55.22M
24.18%-8.21M
18.70%-10.49M
36.96%-13.1M
-24.76%-23.42M
10.26%-63.28M
42.73%-10.82M
27.73%-12.9M
-19.53%-20.79M
-14.63%-18.77M
Income tax
265.00%146K
63.64%-8K
193.33%44K
161.11%47K
117.24%63K
-67.48%40K
15.38%-22K
-28.57%15K
-83.02%18K
31.82%29K
Net income
12.57%-55.37M
24.10%-8.2M
18.45%-10.53M
36.79%-13.15M
-24.90%-23.48M
10.36%-63.32M
42.77%-10.8M
27.73%-12.92M
-18.91%-20.8M
-14.65%-18.8M
Net income continuous Operations
12.57%-55.37M
24.10%-8.2M
18.45%-10.53M
36.79%-13.15M
-24.90%-23.48M
10.36%-63.32M
42.77%-10.8M
27.73%-12.92M
-18.91%-20.8M
-14.65%-18.8M
Minority interest income
Net income attributable to the parent company
12.57%-55.37M
24.10%-8.2M
18.45%-10.53M
36.79%-13.15M
-24.90%-23.48M
10.36%-63.32M
42.77%-10.8M
27.73%-12.92M
-18.91%-20.8M
-14.65%-18.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.57%-55.37M
24.10%-8.2M
18.45%-10.53M
36.79%-13.15M
-24.90%-23.48M
10.36%-63.32M
42.77%-10.8M
27.73%-12.92M
-18.91%-20.8M
-14.65%-18.8M
Basic earnings per share
21.68%-1.12
22.73%-0.17
19.23%-0.21
47.06%-0.27
2.04%-0.48
23.53%-1.43
56.00%-0.22
44.68%-0.26
-8.51%-0.51
-11.36%-0.49
Diluted earnings per share
21.68%-1.12
22.73%-0.17
19.23%-0.21
47.06%-0.27
2.04%-0.48
23.53%-1.43
56.00%-0.22
44.68%-0.26
-8.51%-0.51
-11.36%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -15.48%81.67M-19.42%21.34M-25.39%18.81M-1.52%23.16M-14.29%18.35M29.09%96.63M24.83%26.49M33.75%25.22M31.45%23.52M26.73%21.41M
Operating revenue -15.48%81.67M-19.42%21.34M-25.39%18.81M-1.52%23.16M-14.29%18.35M29.09%96.63M24.83%26.49M33.75%25.22M31.45%23.52M26.73%21.41M
Cost of revenue -16.20%33.79M-29.51%6.96M-28.66%7.09M-14.27%9.78M9.37%9.97M28.15%40.33M7.57%9.87M25.10%9.94M51.00%11.41M34.11%9.12M
Gross profit -14.97%47.88M-13.42%14.39M-23.25%11.72M10.48%13.39M-31.84%8.38M29.76%56.31M37.97%16.62M40.06%15.28M17.16%12.12M21.76%12.29M
Operating expense -20.72%89.06M-20.93%20.12M-27.93%19.15M-20.91%24.38M-13.85%25.42M2.50%112.34M-12.69%25.44M-2.35%26.57M10.87%30.83M15.92%29.5M
Selling and administrative expenses -20.66%69.32M-21.88%15.69M-27.55%14.67M-20.13%19.09M-14.10%19.86M9.68%87.36M-4.13%20.08M1.65%20.25M16.10%23.91M27.10%23.12M
Research and development costs -20.94%19.75M-17.37%4.43M-29.14%4.47M-23.62%5.29M-12.92%5.55M7.60%24.97M-16.68%5.36M15.51%6.31M23.67%6.92M11.62%6.38M
Operating profit 26.50%-41.18M35.07%-5.73M34.25%-7.42M41.24%-11M0.99%-17.04M15.37%-56.03M48.39%-8.82M30.73%-11.29M-7.15%-18.71M-12.08%-17.21M
Net non-operating interest income expense -50.28%-7.92M-59.86%-2.21M-80.60%-2.1M-34.77%-1.94M-29.95%-1.68M-39.58%-5.27M-7.64%-1.38M-19.73%-1.17M-80.88%-1.44M-77.30%-1.29M
Non-operating interest income -28.17%2.51M-58.38%380K-51.49%521K-9.36%668K22.48%937K349.03%3.49M61.59%913K689.71%1.07M1,264.81%737K3,377.27%765K
Non-operating interest expense 19.04%10.43M12.78%2.59M17.24%2.63M19.82%2.61M27.17%2.61M92.38%8.76M24.15%2.29M101.89%2.24M156.18%2.18M174.23%2.05M
Other net income (expense) -208.84%-6.11M56.11%-273K-115.44%-963K73.54%-168K-1,612.00%-4.71M-271.29%-1.98M-18.48%-622K23.20%-447K-172.99%-635K7.09%-275K
Special income (charges) -239.00%-5.55M102.59%16K-253.82%-927K83.40%-88K-1,903.08%-4.55M-1,703.92%-1.64M-24.14%-617K26.61%-262K-145.85%-530K-13.50%-227K
-Less：Restructuring and merger&acquisition 57.40%2.58M-102.59%-16K253.82%927K-83.40%88K594.27%1.58M1,703.92%1.64M24.14%617K-26.61%262K145.85%530K13.50%227K
-Less:Impairment of capital assets --2.97M--0--0--0--2.97M--0--0--0--0--0
Other non- operating income (expenses) -65.01%-566K-5,680.00%-289K80.54%-36K23.81%-80K-235.42%-161K45.98%-343K82.14%-5K17.78%-185K63.29%-105K50.00%-48K
Income before tax 12.74%-55.22M24.18%-8.21M18.70%-10.49M36.96%-13.1M-24.76%-23.42M10.26%-63.28M42.73%-10.82M27.73%-12.9M-19.53%-20.79M-14.63%-18.77M
Income tax 265.00%146K63.64%-8K193.33%44K161.11%47K117.24%63K-67.48%40K15.38%-22K-28.57%15K-83.02%18K31.82%29K
Net income 12.57%-55.37M24.10%-8.2M18.45%-10.53M36.79%-13.15M-24.90%-23.48M10.36%-63.32M42.77%-10.8M27.73%-12.92M-18.91%-20.8M-14.65%-18.8M
Net income continuous Operations 12.57%-55.37M24.10%-8.2M18.45%-10.53M36.79%-13.15M-24.90%-23.48M10.36%-63.32M42.77%-10.8M27.73%-12.92M-18.91%-20.8M-14.65%-18.8M
Minority interest income
Net income attributable to the parent company 12.57%-55.37M24.10%-8.2M18.45%-10.53M36.79%-13.15M-24.90%-23.48M10.36%-63.32M42.77%-10.8M27.73%-12.92M-18.91%-20.8M-14.65%-18.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.57%-55.37M24.10%-8.2M18.45%-10.53M36.79%-13.15M-24.90%-23.48M10.36%-63.32M42.77%-10.8M27.73%-12.92M-18.91%-20.8M-14.65%-18.8M
Basic earnings per share 21.68%-1.1222.73%-0.1719.23%-0.2147.06%-0.272.04%-0.4823.53%-1.4356.00%-0.2244.68%-0.26-8.51%-0.51-11.36%-0.49
Diluted earnings per share 21.68%-1.1222.73%-0.1719.23%-0.2147.06%-0.272.04%-0.4823.53%-1.4356.00%-0.2244.68%-0.26-8.51%-0.51-11.36%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Halozyme Therapeutics
HALO
70.140
New Fortress Energy
NFE
5.950
DexCom
DXCM
83.350
4
YETI Holdings
YETI
27.930
5
Teradata Corp
TDC
22.340
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀